PHARMEDAILY

HyundaiBio·HyundaiADM First to Identify Penetrium Pseudo Resistance Research Accepted by AACR

• 신민준
• 2025.08.29
• 오후 12:25

HyundaiBio begins global trials of universal antiviral drug

• 유진희
• 2025.04.23
• 오후 04:28

Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse]

• 송영두
• 2025.07.13
• 오전 09:50